Xellia
Xellia Pharmaceuticals, commonly referred to as Xellia, is a leading global provider of specialty pharmaceuticals, headquartered in Denmark (DK). Founded in 2008, the company has established a strong presence in the development and manufacturing of anti-infective products, particularly focusing on injectable antibiotics and other critical care medications. With operational facilities in Europe and North America, Xellia is renowned for its commitment to quality and innovation in the pharmaceutical industry. The company’s core offerings include a range of high-potency injectable drugs, which are distinguished by their efficacy and safety profiles. Xellia has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. As a trusted supplier to healthcare providers worldwide, Xellia continues to play a vital role in addressing global health challenges through its specialised pharmaceutical solutions.
DitchCarbon Score
How does Xellia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Xellia's score of 31 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Xellia's reported carbon emissions
Xellia, headquartered in Denmark (DK), currently does not report any specific carbon emissions data for the most recent year. However, the company has set ambitious climate commitments aimed at achieving significant reductions in its carbon footprint. Xellia has established a target to reach zero CO2 emissions from its own operations (Scope 1 and 2) by 2030. Additionally, the company aims to reduce its Scope 3 emissions by approximately 33% by 2033, using 2024 as the baseline year. Furthermore, Xellia is committed to achieving net zero emissions across all scopes by 2045. All production sites have transitioned to sourcing renewable power, reinforcing their commitment to sustainability and environmental responsibility. These initiatives reflect Xellia's proactive approach to addressing climate change and its dedication to reducing its overall environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xellia is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
